Comparison of zotarolimus- and everolimus-eluting stents in patients with ST-elevation myocardial infarction and chronic kidney disease undergoing primary percutaneous coronary intervention

Journal of Cardiology

Volumn 64, Issue 4, 2014, Pages 273-278

  Ahmed, Khurshid ^a,b   Jeong, Myung Ho ^a   Chakraborty, Rabin ^b   Ahmed, Sumera ^b   Hong, Young Joon ^a   Sim, Doo Sun ^a   Park, Keun Ho ^a   Kim, Ju Han ^a   Ahn, Youngkeun ^a   Kang, Jung Chaee ^a   Cho, Myeong Chan ^c   Kim, Chong Jin ^d   Kim, Young Jo ^e  

^a Chonnam National University Medical School   (South Korea)

^b Apollo Gleneagles Hospital   (India)

^c Chungbuk National University Hospital   (South Korea)

^d Kyung Hee University College of Medicine   (South Korea)

^e Young Nam University Hospital   (South Korea)

Author keywords

Chronic kidney failure; Coronary angioplasty; Drug eluting stent; ST segment elevation myocardial infarction

Indexed keywords

EVEROLIMUS; ZOTAROLIMUS; RAPAMYCIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEVICE COMPARISON; DISEASE FREE SURVIVAL; DRUG ELUTING CORONARY STENT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POST TREATMENT SURVIVAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; ANALOGS AND DERIVATIVES; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; COMPLICATION; DRUG ELUTING STENT; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTER;

DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SIROLIMUS;

EID: 84926254569     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.02.002     Document Type: Article

References (27)

1. Lindner A., Charra B., Sherrard D.J., Scribner B.H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974, 290:697-701.
2. Dumaine R., Collet J.P., Tanguy M.L., Mansencal N., Dubois-Rande J.L., Henry P., Steg P.G., Michel P.L., Allouch P., Cohen A., Colin P., Durand E., Montalescot G. Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study). Am J Cardiol 2004, 94:1543-1547. SYCOMORE Investigators.
3. Manjunath G., Tighiouart H., Ibrahim H., MacLeod B., Salem D.N., Griffith J.L., Coresh J., Levey A.S., Sarnak M.J. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003, 41:47-55.
4. Best P.J., Lennon R., Ting H.H., Bell M.R., Rihal C.S., Holmes D.R., Berger P.B. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002, 39:1113-1119.
5. Naidu S.S., Selzer F., Jacobs A., Faxon D., Marks D.S., Johnston J., Detre K., Wilensky R.L. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol 2003, 92:1160-1164.
6. Azar R.R., Prpic R., Ho K.K., Kiernan F.J., Shubrooks S.J., Baim D.S., Popma J.J., Kuntz R.E., Cohen D.J. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 2000, 86:485-489.
7. Best P.J., Berger P.B., Davis B.R., Grines C.L., Sadeghi H.M., Williams B.A., Willerson J.T., Granett J.R., Holmes D.R. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. J Am Coll Cardiol 2004, 44:1786-1791. PRESTO Investigators.
8. Das P., Moliterno D.J., Charnigo R., Mukherjee D., Steinhubl S.R., Sneed J.D., Booth D.C., Ziada K.M. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 2006, 18:405-408.
9. Lemos P.A., Arampatzis C.A., Hoye A., Daemen J., Ong A.T., Saia F., van der Giessen W.J., McFadden E.P., Sianos G., Smits P.C., de Feyter P., Hofma S.H., van Domburg R.T., Serruys P.W. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 2005, 95:167-172.
10. Charytan D., Kuntz R.E. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 2006, 70:2021-2030.
11. Hachinohe D., Jeong M.H., Saito S., Kim M.C., Cho K.H., Ahmed K., Hwang S.H., Lee M.G., Sim D.S., Park K.H., Kim J.H., Hong Y.J., Ahn Y., Kang J.C., Kim J.H., et al. Clinical impact of thrombus aspiration during primary percutaneous coronary intervention: results from Korea Acute Myocardial Infarction Registry. J Cardiol 2012, 59:249-257.
12. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-S266.
13. Apple F.S., Wu A.H., Jaffe A.S. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002, 144:981-986.
14. Kini A.S. Coronary angiography, lesion classification and severity assessment. Cardiol Clin 2006, 24:153-162. v.
15. Manginas A., Gatzov P., Chasikidis C., Voudris V., Pavlides G., Cokkinos D.V. Estimation of coronary flow reserve using the Thrombolysis In Myocardial Infarction (TIMI) frame count method. Am J Cardiol 1999, 83:1562-1565. A7.
16. McCullough P.A., Soman S.S., Shah S.S., Smith S.T., Marks K.R., Yee J., Borzak S. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 2000, 36:679-684.
17. Beattie J.N., Soman S.S., Sandberg K.R., Yee J., Borzak S., Garg M., McCullough P.A. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001, 37:1191-1200.
18. Szczech L.A., Best P.J., Crowley E., Brooks M.M., Berger P.B., Bittner V., Gersh B.J., Jones R., Califf R.M., Ting H.H., Whitlow P.J., Detre K.M., Holmes D. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 2002, 105:2253-2258. Bypass Angioplasty Revascularization Investigation (BARI) Investigators.
19. Bonello L., De Labriolle A., Roy P., Steinberg D.H., Okabe T., Pinto Slottow T.L., Xue Z., Torguson R., Suddath W.O., Satler L.F., Kent K.M., Pichard A.D., Lindsay J., Waksman R. Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol 2008, 102:535-540.
20. Keeley E.C., Kadakia R., Soman S., Borzak S., McCullough P.A. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003, 92:509-514.
21. Hachinohe D., Jeong M.H., Saito S., Ahmed K., Hwang S.H., Lee M.G., Sim D.S., Park K.H., Kim J.H., Hong Y.J., Ahn Y., Kang J.C., Kim J.H., Chae S.C., Kim Y.J., et al. Management of non-ST-segment elevation acute myocardial infarction in patients with chronic kidney disease (from the Korea Acute Myocardial Infarction Registry). Am J Cardiol 2011, 108:206-213.
22. Rubenstein M.H., Harrell L.C., Sheynberg B.V., Schunkert H., Bazari H., Palacios I.F. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era. Circulation 2000, 102:2966-2972.
23. McCullough P.A. Cardiorenal risk: an important clinical intersection. Rev Cardiovasc Med 2002, 3:71-76.
24. Kirtane A.J., Gupta A., Iyengar S., Moses J.W., Leon M.B., Applegate R., Brodie B., Hannan E., Harjai K., Jensen L.O., Park S.J., Perry R., Racz M., Saia F., Tu J.V., et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009, 119:3198-3206.
25. Abdel-Latif A., Mukherjee D., Mesgarzadeh P., Ziada K.M. Drug-eluting stents in patients with end-stage renal disease: meta-analysis and systematic review of the literature. Catheter Cardiovasc Interv 2010, 76:942-948.
26. Serruys P.W., Silber S., Garg S., van Geuns R.J., Richardt G., Buszman P.E., Kelbaek H., van Boven A.J., Hofma S.H., Linke A., Klauss V., Wijns W., Macaya C., Garot P., DiMario C., et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 2010, 363:136-146.
27. Nakazawa G. Stent thrombosis of drug eluting stent: pathological perspective. J Cardiol 2011, 58:84-91.